IPG Photonics Corporation filed its quarterly report on Form 10-Q with the SEC on November 3, 2026, covering the three and nine months ended September 30, 2026, and reporting net sales of $287.5 million for the third quarter.

Key Highlights

  • Q3 2026 net sales: $287,500 thousand, compared with $250,792 thousand in Q3 2025, according to the filing.
  • Q3 2026 net income: $20,273 thousand, or $0.47 per diluted share, versus $7,463 thousand, or $0.18 per diluted share, in Q3 2025.
  • Nine-month net income: $27,099 thousand ($0.63 diluted EPS) for the nine months ended September 30, 2026, compared with $17,826 thousand ($0.42 diluted EPS) in the same period of 2025.
  • Impairment charges: The filing reports $17,805 thousand in impairment charges for the nine months ended September 30, 2026, with no comparable charge in the prior-year period.
  • Settlement of litigation matters: $13,334 thousand in charges related to settlement of litigation matters recorded in the nine-month period, with no comparable amount in 2025.
  • Cash and equivalents: $710,688 thousand as of September 30, 2026, up from $403,790 thousand at December 31, 2025.
  • Shares outstanding: 42,508,140 shares of common stock outstanding as of November 2, 2026, per the filing.

IPG Photonics Reports Higher Q3 Revenue and Income Amid Impairment and Litigation Charges

According to the Form 10-Q filed by IPG Photonics Corporation (NASDAQ:IPGP) on November 3, 2026, the company reported net sales of $287,500 thousand for the three months ended September 30, 2026, an increase from $250,792 thousand in the same quarter of 2025. Gross profit for Q3 2026 was $117,054 thousand, compared with $99,005 thousand in Q3 2025. Operating income for the quarter was $20,777 thousand, up from $7,855 thousand a year earlier, the filing disclosed.

For the nine-month period ended September 30, 2026, the filing reports net sales of $831,577 thousand versus $729,306 thousand in the first nine months of 2025. Total operating expenses for the nine months were $311,505 thousand and included $17,805 thousand in impairment charges and $13,334 thousand in settlement of litigation matters, neither of which appeared in the comparable 2025 period. Operating income for the nine months was $17,572 thousand, compared with $9,786 thousand in 2025, according to the filing.

The condensed consolidated balance sheet as of September 30, 2026, shows total assets of $2,472,043 thousand and total liabilities of $317,095 thousand, leaving total stockholders' equity of $2,154,948 thousand. The company reported net cash provided by operating activities of $78,531 thousand for the nine months ended September 30, 2026, compared with $46,535 thousand in the prior-year period. Cash and cash equivalents rose to $710,688 thousand from $403,790 thousand at December 31, 2025, the filing stated. Treasury stock held at September 30, 2026, totaled 14,872,528 shares at a cost of $1,558,277 thousand.

What Was Disclosed

IPG Photonics filed its Form 10-Q for the quarter ended September 30, 2026, disclosing revenue growth, improved net income, notable impairment and litigation settlement charges during the nine-month period, and a significant increase in cash and cash equivalents versus year-end 2025.